The Newswire

Your daily serving of financial goodness

Bradken Rejects Unsolicited Takeover Bid

Bradken Rejects Unsolicited Takeover Bid
Apr 02, 2015 By Matthew Dibb

Mining equipment and rolling rock supplier Bradken Limited (ASX:BKN) received an unsolicited takeover bid from Pacific Equity Partners (PEP) and Koch Industries on Wednesday night. Although the price tag for the bid came in at a 30 per cent premium relative to the share price, the company rejected the non-binding $2.50 per share proposal after the board said the proposal did not “represent fair value”. The bid for the company was around half of a similar offer made by PEP and Bain Capital last December when the share price was approaching $4.80 per share. The proposal was withdrawn the next month after the share price of Bradken followed a downward trend, falling more than 50 per cent in the following months.

Following the news of the takeover bid, the share price of BKN has soared. It has risen 25c, or 12.89 per cent, at $2.19 per share around 2:25pm on Thursday. Despite the rally today, BKN has fallen 47.36 per cent in the last 12 months and 53.70 per cent so far this year. In February, the company reported a half-year net loss of around $93m as it continued to struggle amid a downturn in the mining industry. The board members of Bradken said the proposal was “subject to a number of conditions including certain financial due diligence.” However, the board came to a quick decision and ultimately decided against the takeover bid. “The board of Bradken considered the proposal and determined that it does not represent fair value and accordingly determined not to engage further.”

 

Share this article

Matthew Dibb Author: Matthew Dibb Apr 02, 2015

Matthew has an extensive track record in equity markets and derivative advisory. Spanning a career in several investment banks and prviate wealth groups including Macquarie Bank, his specialist knowledge relates to capital market advisory and equity market analytics. Matthew has a diploma in Financial Advisory, Applied Finance and is ADA 1 & 2 accredited.

Medical marijuana treatment for animals?

Demand for pot companies reached an all-time high in 2017 as overhyped medical marijuana companies flooded the local market, taking advantage of investor appetite for ‘the next big thing’.

Author: Simon Herrmann Oct 18, 2017

Errors

Sign Up for Free Trial
Subscribe
Recent Tweets
Recent News